High-risk human papillomavirus seroprevalence in men and women of six different ethnicities in Amsterdam, the Netherlands: The HELIUS study

Papillomavirus Research

Volumn 3, Issue , 2017, Pages 57-65

  Alberts, C J ^a,b   Michel, A ^c   Bruisten, S ^a,b   Snijder, M B ^b   Prins, M ^a,b   Waterboer, T ^c   Schim van der Loeff, M F ^a,b  

^a DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cross sectional studies; Epidemiology; Ethnic; health status disparities; HELIUS; Human Papillomavirus; The Netherlands

Indexed keywords

ADULT; AFRICAN; AGE; ARTICLE; BLOOD SAMPLING; DEMOGRAPHY; DUTCHMAN; ETHNIC GROUP; ETHNICITY; FEMALE; GHANAIAN; HEALTH DISPARITY; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; MAJOR CLINICAL STUDY; MALE; MOROCCAN; NETHERLANDS; PAPILLOMAVIRUS INFECTION; SEROPREVALENCE; SEX DIFFERENCE; SEXUAL BEHAVIOR; SOUTH ASIAN; SURINAMESE; TURKISH CITIZEN;

EID: 85013673059     PISSN: None     EISSN: 24058521     Source Type: Journal    
DOI: 10.1016/j.pvr.2017.01.003     Document Type: Article

References (46)

1. [1] Fenton, K.A., Mercer, C.H., McManus, S., Erens, B., Wellings, K., MacDowall, W., Byron, C.L., Copas, A.J., Nanchahal, K., Field, J., Johnson, A.M., Ethnic variations in sexual behaviour in Great Britain and risk of sexually transmitted infections: a probability survey. Lancet 365 (2005), 1246–1255.
2. [2] Boyer, C.B., Shafer, M.A.B., Pollack, L.M., Canchola, J., Moncada, J., Schachter, J., Sociodemographic markers and behavioral correlates of sexually transmitted infections in a nonclinical sample of adolescent and young adult women. J. Infect. Dis. 194 (2006), 307–315.
3. [3] Buzi, R.S., Weinman, M.L., Smith, P.B., Ethnic differences in STD rates among female adolescents. Adolescence 33 (1998), 312–318.
4. [4] Fenton, K., Johnson, M., Nicoll, A., Race, ethnicity, and sexual health. Br. Med. J. 314 (1997), 1703–1708.
5. [5] Matser, A., Luu, N., Geskus, R., Heijman, T., Heiligenberg, M., van Veen, M., Schim van der Loeff, M., Higher Chlamydia trachomatis prevalence in ethnic minorities does not always reflect higher sexual risk behaviour. PLoS One 8 (2013), 4–11.
6. [6] Woestenberg, P.J., van Oeffelen, A.A.M., Stirbu-Wagner, I., van Benthem, B.H.B., van Bergen, J.E.A.M., van den Broek, I.V.F., Comparison of STI-related consultations among ethnic groups in the Netherlands: an epidemiologic study using electronic records from general practices. BMC Fam. Pract. 16 (2015), 1–8.
7. [7] van Bergen, J.E.A.M., Spaargaren, J., Götz, H.M., Veldhuijzen, I.K., Bindels, P.J.E., Coenen, T.J., Broer, J., de Groot, F., Hoebe, C.J.P.A., Richardus, J., van Schaik, D., Verhooren, M., Population prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae in the Netherlands. Should asymptomatic persons be tested during population-based Chlamydia screening also for gonorrhoea or only if chlamydial infection is found?. (the P.C. Study-group) BMC Infect. Dis., 6, 2006.
8. [8] Hooykaas, C., van der Velde, F.W., van der Linden, M.M., van Doornum, G.J., Coutinho, R.A., The importance of ethnicity as a risk factor for STDs and sexual behaviour among heterosexuals. Genitourin. Med. 67 (1991), 378–383.
9. [9] Walboomers, J.M.M., Jacobs, M.V., Manos, M.M., Bosch, F.X., Kummer, J.A., Shah, K., Snijders, P.J.F., Peto, J., Meijer, C.J.L.M., Muñoz, N., Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999), 12–19.
10. [10] Schiffman, M., Castle, P.E., Jeronimo, J., Rodriguez, A.C., Wacholder, S., Human papillomavirus and cervical cancer. Lancet 370 (2007), 890–907.
11. [11] Trottier, H., Burchell, A.N., Epidemiology of mucosal human papillomavirus infection and associated diseases. Public Health Genom. 12 (2009), 291–307.
12. [12] Bruni, L., Diaz, M., Barrionuevo-rosas, L., Herrero, R., Bray, F., Bosch, F.X., De Sanjosé, S., Castellsagué, X., Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob. Heal. 4 (2016), 453–463.
13. [13] Smith, J.S., Gilbert, P.A., Melendy, A., Rana, R.K., Pimenta, J.M., Age-specific prevalence of human papillomavirus infection in males: a global review. J. Adolesc. Heal. 48 (2011), 540–552.
14. [14] Walsh, T., Bertozzi-Villa, C., Schneider, J.A., Systematic review of racial disparities in human papillomavirus-associated anal dysplasia and anal cancer among men who have sex with men. Am. J. Public Health 105 (2015), e34–e45.
15. [15] Banister, C.E., Messersmith, A.R., Cai, B., Spiryda, L.B., Glover, S.H., Pirisi, L., Creek, K.E., Disparity in the persistence of high-risk human papillomavirus genotypes between African American and European American women of college age. J. Infect. Dis. 211 (2015), 100–108.
16. [16] Veldhuijzen, N.J., Snijders, P.J.F., Reiss, P., Meijer, C.J.L.M., van de Wijgert, J.H.H.M., Factors affecting transmission of mucosal human papillomavirus. Lancet Infect. Dis. 10 (2010), 862–874.
17. [17] Kjaer, S.K., Munk, C., Winther, J.F., Jørgensen, H.O., Meijer, C.J.L.M., van den Brule, A.J.C., Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish Soldiers. Cancer Epidemiol Biomark. Prev. 14 (2005), 1528–1533.
18. [18] Kjaer, S.K., Chackerian, B., van den Brule, A.J.C., Kru, S., Paull, G., Walbomers, J.M.M., Schiller, J.T., Bock, J.E., Sherman, M.E., Lowy, D.R., Meijer, C.L.M., High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (Intercourse). Cancer Epidemiol. Biomark. Prev. 10 (2001), 101–106.
19. [19] Vaccarella, S., Franceschi, S., Herrero, R., Muñoz, N., Snijders, P.J.F., Clifford, G.M., Smith, J.S., Lazcano-Ponce, E., Sukvirach, S., Shin, H.R., Sanjos, S. De, Molano, M., Matos, E., Ferreccio, C., Anh, P.T.H., Thomas, J.O., Meijer, C.J.L.M., Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiol. Biomark. Prev. 15 (2006), 326–333.
20. [20] Wang, S.S., Schiffman, M., Shields, T.S., Herrero, R., Hildesheim, A., Bratti, M.C., Sherman, M.E., Rodriguez, A.C., Castle, P.E., Morales, J., Alfaro, M., Wright, T., Chen, S., Clayman, B., Burk, R.D., Viscidi, R.P., Seroprevalence of human papillomavirus-16, −18, −31, and −45 in a population-based cohort of 10000 women in Costa Rica. Br. J. Cancer 89 (2003), 1248–1254.
21. [21] Alberts, C.J., Vos, R.A., Borgdorff, H., Vermeulen, W., Van Bergen, J., Bruisten, S., Geerlings, S., Snijder, M., van Houdt, R., Morré, S., de Vries, H., van de Wijgert, J., Prins, M., Schim van der Loeff, M., Vaginal high-risk human papillomavirus infection in a cross-sectional study among women of six different ethnicities in Amsterdam, the Netherlands: the HELIUS study. PubMed Commons Sex. Transm. Infect. 92 (2016), 611–618.
22. [22] Mollers, M., Scherpenisse, M., van der Klis, F.R.M., King, A.J., van Rossum, T.G.J., van Logchem, E.M., Feltkamp, M.C., Meijer, C.J.L.M., Snijders, P.J.F., Boot, H.J., de Melker, H.E., Prevalence of genital HPV infections and HPV serology in adolescent girls, prior to vaccination. Cancer Epidemiol. 36 (2012), 519–524.
23. [23] Gök, M., Heideman, D.A.M., Van Kemenade, F.J., De Vries, A.L.M., Berkhof, J., Rozendaal, L., Beliën, J.A.M., Overbeek, L., Babović, M., Snijders, P.J.F., Meijer, C.J.L.M., Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme: characteristics of the responders. Eur. J. Cancer 48 (2012), 1799–1808.
24. [24] Heiligenberg, M., Alberts, C.J., Waterboer, T., Speksnijder, A.G.C.L., De Vries, H.J.C., Pawlita, M., Schim van der Loeff, M.F.S., Route of sexual exposure is independently associated with seropositivity to HPV-16 and HPV-18 among clients of an STI clinic in the Netherlands. J. Infect. Dis. 208 (2013), 1081–1085.
25. [25] Giuliano, A.R., Viscidi, R., Torres, B.N., Ingles, D.J., Sudenga, S.L., Villa, L.L., Luiza Baggio, M., Abrahamsen, M., Quiterio, M., Salmeron, J., Lazcano-Ponce, E., Seroconversion following anal and genital HPV infection in men: the HIM study. Papillomavirus Res. 1 (2015), 109–115.
26. [26] Vriend, H.J., Bogaards, J.A., van der Klis, F.R.M., Scherpenisse, M., Boot, H.J., King, A.J., van der Sande, M.A.B., Patterns of Human Papillomavirus DNA and antibody positivity in young males and females, suggesting a site-specific natural course of infection. PLoS One, 8, 2013.
27. [27] Stronks, K., Snijder, M.B., Peters, R.J.G., Prins, M., Schene, A.H., Zwinderman, A.H., Unravelling the impact of ethnicity on health in Europe: the HELIUS study. BMC Public Health, 13, 2013, 402.
28. [28] Stronks, K., Kulu-Glasgow, I., Agyemang, C., The utility of ‘country of birth’ for the classification of ethnic groups in health research: the Dutch experience. Ethn. Health 14 (2009), 255–269.
29. [29] Waterboer, T., Sehr, P., Michael, K.M., Franceschi, S., Nieland, J.D., Joos, T.O., Templin, M.F., Pawlita, M., Multiplex human papillomavirus serology based on in situ-purified glutathione S-transferase fusion proteins. Clin. Chem. 51 (2005), 1845–1853.
30. [30] Clifford, G.M., Shin, H.R., Oh, J.K., Waterboer, T., Ju, Y.H., Vaccarella, S., Quint, W., Pawlita, M., Franceschi, S., Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea. Cancer Epidemiol. Biomark. Prev. 16 (2007), 1874–1879.
31. [31] StataCorp. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP., (n.d.), 2015.
32. [32] Kreimer, A.R., Johansson, M., Waterboer, T., Kaaks, R., Chang-Claude, J., Drogen, D., Tjønneland, A., Overvad, K., Quirós, J.R., González, C.A., Sánchez, M.J., Larrañaga, N., Navarro, C., Barricarte, A., Travis, R.C., Khaw, K.T., Wareham, N., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Peeters, P.H.M., Panico, S., Masala, G., Grioni, S., Tumino, R., Vineis, P., Bueno-de-Mesquita, H.B., Laurell, G., Hallmans, G., Manjer, J., Ekström, J., Skeie, G., Lund, E., Weiderpass, E., Ferrari, P., Byrnes, G., Romieu, I., Riboli, E., Hildesheim, A., Boeing, H., Pawlita, M., Brennan, P., Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J. Clin. Oncol. 31 (2013), 2708–2715.
33. [33] Kreimer, A.R., Brennan, P., Lang Kuhs, K.A., Waterboer, T., Clifford, G., Franceschi, S., Michel, A., Willhauck-Fleckenstein, M., Riboli, E., Castellsagué, X., Hildesheim, A., Fortner, R.T., Kaaks, R., Palli, D., Ljuslinder, I., Panico, S., Clavel-Chapelon, F., Boutron-Ruault, M.-C., Mesrine, S., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Peeters, P.H., Cross, A.J., Bueno-de-Mesquita, H.B., Vineis, P., Larrañaga, N., Pala, V., Sánchez, M.-J., Navarro, C., Barricarte, A., Tumino, R., Khaw, K.-T., Wareham, N., Boeing, H., Steffen, A., Travis, R.C., Quirós, J.R., Weiderpass, E., Pawlita, M., Johansson, M., Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study. J. Clin. Oncol. 33 (2015), 877–884.
34. [34] Bertisch, B., Franceschi, S., Lise, M., Vernazza, P., Keiser, O., Schöni-Affolter, F., Bouchardy, C., Dehler, S., Levi, F., Jundt, G., Ess, S., Pawlita, M., Kovari, H., Wandeler, G., Calmy, A., Cavassini, M., Stöckle, M., Clifford, G., Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study. Am. J. Epidemiol. 178 (2013), 877–884.
35. [35] Markowitz, L.E., Sternberg, M., Dunne, E., McQuillan, G., Unger, E.R., Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003–2004. J. Infect. Dis. 200 (2009), 1059–1067.
36. [36] Michael, K.M., Waterboer, T., Sehr, P., Rother, A., Reidel, U., Boeing, H., Bravo, I.G., Schlehofer, J., Gärtner, B.C., Pawlita, M., Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog., 4, 2008.
37. [37] Heiligenberg, M., Michael, K.M., Kramer, M.A., Pawlita, M., Prins, M., Coutinho, R.A., Dukers-Muijrers, N.H., Waterboer, T., Seroprevalence and determinants of eight high-risk human papillomavirus types in homosexual men, heterosexual men, and women: a population-based study in Amsterdam. Sex Transm. Dis. 37 (2010), 672–680.
38. [38] Wang, S.S., Schiffman, M., Herrero, R., Carreon, J., Hildesheim, A., Rodriguez, A.C., Bratti, M.C., Sherman, M.E., Morales, J., Guillen, D., Alfaro, M., Clayman, B., Burk, R.D., Viscidi, R.P., Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica. Br. J. Cancer 91 (2004), 1269–1274.
39. [39] Tiggelaar, S.M., Lin, M.J., Viscidi, R.P., Ji, J., Smith, J.S., Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global review. J. Adolesc. Heal. 50 (2012), 110–131.
40. [40] Scherpenisse, M., Mollers, M., Schepp, R.M., Boot, H.J., de Melker, H.E., Meijer, C.J.L.M., Berbers, G.A.M., van der Klis, F.R.M., Seroprevalence of seven high-risk HPV types in The Netherlands. Vaccine 30 (2012), 6686–6693.
41. [41] Alberts, C.J., van Rooijen, M.S., Prins, M., Pawlita, M., Schim, M.F., van der Loeff, Waterboer, T., HIV is an important risk factor for human papillomavirus types 16 and 18 seropositivity among sexually active men who have sex with men. Sex Transm. Dis. 42 (2015), 129–134.
42. [42] van Veen, M.G., Presanis, A.M., Conti, S., Xiridou, M., Stengaard, A.R., Donoghoe, M.C., van Sighem, A.I., van der Sande, M.A., De Angelis, D., National estimate of HIV prevalence in the Netherlands: comparison and applicability of different estimation tools. AIDS 25 (2011), 229–237, 10.1097/QAD.0b013e32834171bc.
43. [43] A.A.M. Oeffelen, F. van Aar, I.V.F. van den Broek, E.L.M. op de Coul, P.J. Woestenberg, J. Heijne, C. den Daas, C. Hofstraat, A. van Sighem, M. Nielen, Annual report: Sexually transmitted infections, including HIV, in the Netherlands in 2014, Bilthoven, The Netherlands, 2014.
44. Edelstein, Z.R., Carter, J.J., Garg, R., Winer, R.L., Feng, Q., Galloway, D.A., Koutsky, L.A., Serum antibody response following genital {alpha}9 human papillomavirus infection in young men. J. Infect. Dis. 204 (2011), 209–216.
45. [45] Carter, J.J., Koutsky, L.A., Wipf, G.C., Christensen, N.D., Lee, S.K., Kuypers, J., Kiviat, N., Galloway, D.A., The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J. Infect. Dis. 174 (1996), 927–936.
46. [46] Kovaleva, A., Alberts, T., Waterboer, Catharina J., Michel, A., Snijder, W., Vermeulen, Marieke B., Coyer, L., Prins, M., Schim van der Loeff, M., A cross-sectional study on the concordance between vaginal HPV DNA detection and type-specific antibodies in a multi-ethnic cohort of women from Amsterdam, the Netherlands – the HELIUS study. BMC Infect. Dis., 16, 2016.